{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:46:43Z","timestamp":1790275603541,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:00:00Z","timestamp":1490918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Walter Bruckerhoff Foundation, Swiss National Science Foundation","award":["CRSII3 147697\/1"],"award-info":[{"award-number":["CRSII3 147697\/1"]}]}],"content-domain":{"domain":["jtoelsevier.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jtho.2017.03.023","type":"journal-article","created":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T20:26:26Z","timestamp":1491337586000},"page":"1309-1319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["A Novel BRCA1-Associated Protein-1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1-Mediated DNA Repair"],"prefix":"10.1016","volume":"12","author":[{"given":"Rossella","family":"Parrotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Okonska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ronner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Weder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Stahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Penengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Felley-Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2017.03.023_bib1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Guo","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2017.03.023_bib2","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1158\/0008-5472.CAN-14-1328","article-title":"Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma","volume":"74","author":"Xu","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2017.03.023_bib3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2017.03.023_bib4","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/onc.2015.243","article-title":"Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma","volume":"35","author":"Napolitano","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jtho.2017.03.023_bib5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2017.03.023_bib6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.jtho.2017.03.023_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1158\/0008-5472.CAN-08-3355","article-title":"BRCA1-associated protein 1 interferes with BRCA1\/BARD1 RING heterodimer activity","volume":"69","author":"Nishikawa","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2017.03.023_bib8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","article-title":"BRCA1 and BRCA2: 1994 and beyond","volume":"4","author":"Narod","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtho.2017.03.023_bib9","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1158\/0008-5472.CAN-08-0365","article-title":"BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization","volume":"68","author":"Ventii","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2017.03.023_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature08966","article-title":"Histone H2A deubiquitinase activity of the polycomb repressive complex PR-DUB","volume":"465","author":"Scheuermann","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2017.03.023_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pena-Llopis","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2017.03.023_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.1309085110","article-title":"Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair","volume":"111","author":"Yu","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtho.2017.03.023_bib13","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/cdd.2016.91","article-title":"Alternative splicing and cell survival: from tissue homeostasis to disease","volume":"23","author":"Paronetto","year":"2016","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jtho.2017.03.023_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lungcan.2008.08.014","article-title":"Functional inactivation of NF2\/merlin in human mesothelioma","volume":"64","author":"Thurneysen","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2017.03.023_bib15","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","article-title":"High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas","volume":"92","author":"Bianchi","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtho.2017.03.023_bib16","first-page":"1227","article-title":"Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer","volume":"55","author":"Sekido","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2017.03.023_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<554::AID-IJC14>3.0.CO;2-6","article-title":"Heterogeneity of mesothelioma cell lines as defined by altered genomic structure and expression of the NF2 gene","volume":"77","author":"Deguen","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jtho.2017.03.023_bib18","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1038\/sj.onc.1206593","article-title":"Hemizygosity of Nf2 is associated with increased susceptibility to\u00a0asbestos-induced peritoneal tumours","volume":"22","author":"Fleury-Feith","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jtho.2017.03.023_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ccr.2008.01.030","article-title":"A\u00a0conditional mouse model for malignant mesothelioma","volume":"13","author":"Jongsma","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtho.2017.03.023_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/geno.2001.6672","article-title":"Multiple transcription initiation sites, alternative splicing, and differential polyadenylation contribute to the complexity of human neurofibromatosis 2 transcripts","volume":"79","author":"Chang","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.jtho.2017.03.023_bib21","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.onc.1201418","article-title":"Interdomain binding mediates tumor growth suppression by the NF2 gene product","volume":"15","author":"Sherman","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.jtho.2017.03.023_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/hmg\/7.3.335","article-title":"Defects in neurofibromatosis 2 protein function can arise at multiple levels","volume":"7","author":"Gutmann","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jtho.2017.03.023_bib23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1101\/gad.13.8.978","article-title":"Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein","volume":"13","author":"Giovannini","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.jtho.2017.03.023_bib24","doi-asserted-by":"crossref","first-page":"e1757","DOI":"10.1038\/cddis.2015.124","article-title":"Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K\/mTOR inhibitors","volume":"6","author":"Echeverry","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jtho.2017.03.023_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1476-4598-13-119","article-title":"GAS5 long non-coding RNA in malignant pleural mesothelioma","volume":"13","author":"Renganathan","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jtho.2017.03.023_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2199-10-55","article-title":"RNF168, a new RING finger, MIU-containing protein that modifies chromatin by ubiquitination of histones H2A and H2AX","volume":"10","author":"Pinato","year":"2009","journal-title":"BMC Mol Biol"},{"key":"10.1016\/j.jtho.2017.03.023_bib27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bcp.2004.11.007","article-title":"Inducible nitric oxide synthase-dependent stimulation of PKGI and phosphorylation of VASP in human embryonic kidney cells","volume":"69","author":"Andre","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jtho.2017.03.023_bib28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.0305-1846.2000.00288.x","article-title":"Expression of poly(ADP-ribose) polymerase and distribution of poly(ADP-ribosyl)ation in glioblastoma and in a glioma multicellular tumour spheroid model","volume":"26","author":"Wharton","year":"2000","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.jtho.2017.03.023_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.currproblcancer.2010.12.002","article-title":"PARP inhibitor treatment in ovarian and breast cancer","volume":"35","author":"Weil","year":"2011","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.jtho.2017.03.023_bib30","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing\u00a0of BRCA2-deficient tumours with inhibitors of\u00a0poly(ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2017.03.023_bib31","doi-asserted-by":"crossref","first-page":"7158","DOI":"10.1128\/MCB.25.16.7158-7169.2005","article-title":"Spontaneous homologous recombination is induced by collapsed replication forks that are caused by endogenous DNA single-strand breaks","volume":"25","author":"Saleh-Gohari","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jtho.2017.03.023_bib32","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1006\/jmbi.2001.4564","article-title":"DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells","volume":"307","author":"Arnaudeau","year":"2001","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jtho.2017.03.023_bib33","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1158\/2159-8290.CD-11-0348","article-title":"PI3K inhibition impairs BRCA1\/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition","volume":"2","author":"Ibrahim","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtho.2017.03.023_bib34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/path.3979","article-title":"BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma","volume":"227","author":"Busacca","year":"2012","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jtho.2017.03.023_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/cas.12698","article-title":"Functional differences between wild-type and mutant-type BAP1 tumor suppressor against malignant mesothelioma cells","author":"Hakiri","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jtho.2017.03.023_bib36","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1038\/onc.2013.533","article-title":"Hallmarks of alternative splicing in cancer","volume":"33","author":"Oltean","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.jtho.2017.03.023_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12862-016-0781-2","article-title":"Corepressor diversification by alternative mRNA splicing is species specific","volume":"16","author":"Privalsky","year":"2016","journal-title":"BMC Evol Biol"},{"key":"10.1016\/j.jtho.2017.03.023_bib38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-biochem-060614-034316","article-title":"Mechanisms and regulation of alternative pre-mRNA splicing","volume":"84","author":"Lee","year":"2015","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jtho.2017.03.023_bib39","doi-asserted-by":"crossref","first-page":"10292","DOI":"10.1038\/ncomms10292","article-title":"BAP1\/ASXL1 recruitment and activation for H2A deubiquitination","volume":"7","author":"Sahtoe","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtho.2017.03.023_bib40","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.molcel.2014.03.002","article-title":"Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O","volume":"54","author":"Mashtalir","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.jtho.2017.03.023_bib41","doi-asserted-by":"crossref","first-page":"E4338","DOI":"10.1073\/pnas.1522223113","article-title":"Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion","volume":"113","author":"Juvekar","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtho.2017.03.023_bib42","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1158\/2159-8290.CD-11-0336","article-title":"Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer","volume":"2","author":"Juvekar","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtho.2017.03.023_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1593\/neo.131694","article-title":"Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness","volume":"16","author":"De","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.jtho.2017.03.023_bib44","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1158\/1078-0432.CCR-15-2225","article-title":"Phase I study of apitolisib (GDC-0980), dual phosphatidylinositol-3-kinase and mammalian target of rapamycin kinase inhibitor, in patients with advanced solid tumors","volume":"22","author":"Dolly","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2017.03.023_bib45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086417302745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086417302745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T23:57:12Z","timestamp":1535932632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086417302745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1556086417302745"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2017.03.023","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel BRCA1-Associated Protein-1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1-Mediated DNA Repair","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2017.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}